Trinucleotide repeats in neurogenetic disorders

Annual Review of Neuroscience

Volumn 19, Issue , 1996, Pages 79-107

  Paulson, H L ^a   Fischbeck, K H ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

expanded repeats; genetic instability; Huntington's disease; neurodegeneration; polyglutamine repeats

Indexed keywords

TRINUCLEOTIDE;

CEREBELLAR ATAXIA; FRAGILE X SYNDROME; GENE EXPRESSION; GENETIC DISORDER; GENETIC LINKAGE; HUMAN; HUNTINGTON CHOREA; MACHADO JOSEPH DISEASE; MUSCLE ATROPHY; MYOTONIC DYSTROPHY; NERVE DEGENERATION; NEUROLOGIC DISEASE; PRIORITY JOURNAL; REVIEW; TANDEM REPEAT;

EID: 0029968460     PISSN: 0147006X     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.ne.19.030196.000455     Document Type: Review

References (143)

1. Abitbol M, Menini C, Delezoide A-L, Rhyner T, Vekemans M, et al. 1993. Nucleus basalis magnocellularis and hippocampus are the major sites of FMR-1 expression in the human fetal brain. Nat. Genet. 4:147-53
2. Andrew SE, Goldberg YP, Kremer B, Telenius H, Theilman J, et al. 1993. The relationship between trinucleotide (CAG) repeat length and clinical features of Huntington's disease. Nat. Genet. 4:398-403
3. Anvret M, Ahlberg G, Grandell U, Hedberg B, Johnson K, et al. 1993. Larger expansions of the CTG repeat in muscle compared to lymphocytes from patients with myotonic dystrophy. Hum. Mol. Genet. 2: 1397-400
4. Ashizawa T, Dubel JR, Dunne PW, Dunne CJ, Fu H-Y, et al. 1992. Anticipation in myotonic dystrophy. II. Complex relationships between clinical findings and structure of the GCT repeat. Neurology 42:1877-83
5. Ashley CT, Sutcliffe JS, Kunst CB, Leiner HA, Eichler EE, et al. 1993a. Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG-repeat. Nat. Genet. 4:244-51
6. Ashley CT, Wilkinson KD, Reines D, Warren ST. 1993b. FMR-1 protein: conserved RNP family domains and selective RNA binding. Science 262:563-66
7. Aslandis C, Jansen G, Amemiya C, Shutler G, Mahadevan M, et al. 1992. Cloning of the essential myotonic dystrophy region and mapping of the putative defect. Nature 355: 548-51
8. Banfi S, Servadio A, Chung M, Kwiatkowski TJ, McCall AE, et al. 1994. Identification and characterization of the gene causing type 1 spinocerebellar ataxia. Nat. Genet. 7:513-20
9. Bates G, Lehrach H. 1994. Trinucleotide repeat expansions and human genetic disease. Bio-Essays 16:277-84
10. Beal MF. 1992. Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative diseases? Neurology 31:119-30
11. Beal MF, Brouillet E, Jenkins BG, Ferrante RJ, Kowall NW, et al. 1993. Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid. J. Neurosci. 13: 4181-92
12. Bell MV, Hirst MC, Nakahori Y, MacKinnon RN, Roche A, et al. 1991. Physical mapping across the fragile X: hypermethylation and clinical expression of the fragile X syndrome. Cell 64:861-66
13. Bergoffen J, Kant J, Sladky J, McDonald-McGinn M, Zackai E, Fischbeck KH. 1994. Paternal transmission of congenital myotonic dystrophy. J. Med. Genet. 31:518-20
14. Bingham PM, Scott MO, Wang S, McPhaul MJ, Wilson EM, et al. 1995. Stability of an expanded trinucleotide repeat in the androgen receptor gene in transgenic mice. Nat. Genet. 9:191-96
15. Broholm J, Cassiman J-J, Craufurd D, Falek A, Farmer-Little C, et al. 1994. Guidelines for the molecular genetics predictive test in Huntington's disease. Neurology 44:1533-36
16. Brook JD, McCurrach ME, Harley HG, Buckler AJ, Church D, et al. 1992. Molecular basis of myotonic dystrophy: Expansion of a trinucleotide (CTG) repeat at the 3′ end of a transcript encoding a protein kinase family member. Cell 68:799-808
17. Bruhn L, Hwang-Shum JJ, Sprague GF. 1992. The N-terminal 96 residues of MCMI, a regulator of cell type-specific genes in Saccharomyces cerevisiae, are sufficient for DNA binding, transcription activation, and interaction with alpha 1. Mol. Cell. Biol. 12: 3563-72
18. Burke JR, Wingfield MS, Lewis KE, Roses AD, Lee JE, et al. 1994. The Haw River syndrome: dentatorubral-pallidoluysian atrophy (DRPLA) in an African-American family. Nat. Genet. 7:521-24
19. Burright E, Clark HB, Servadio A, Matilla T, Feddersen RM, et al. 1995. SCA1 transgenic mice: a model for neurodegeneration caused by trinucleotide expansion. Submitted
20. Buxton J, Shelbourne P, Davies J, Jones C, Van Tongeren T, et al. 1992. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 355: 547-48
21. Chamberlain NL, Driver ED, Miesfeld RL. 1994. The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucl. Acids Res. 22:3181-86
22. Chung M, Ranum LPW, Duvick LA, Servadio A, Zoghbi HY, et al. 1993. Evidence for a mechanism predisposing to intergenerational CAG repeat instability in spinocerebellar ataxia type 1. Nat. Genet. 5:254-58
23. Creusot F, Verdiere J, Gaisne M, Slonimski PP. 1988. CYP1 (HAP1) regulator of oxygen-dependent gene expression in yeast. J. Mol. Biol. 204:263-76
24. De Boulle K, Verkerk AJMH, Reyniers E, Vits L, Hendricks J, et al. 1993. A point mutation in the FMR-1 gene associated with fragile X mental retardation. Nat. Genet. 3:31-35
25. Devys D, Lutz Y, Rouyer N, Bellocq JP, Mandel J-L. 1993. The FMR-1 protein is cytoplasmic, most abundant in neurons, and appears normal in carriers of the fragile X premutation. Nat. Genet. 4:335-40
26. DiBenedetto AJ, Pittman RN. 1995. Death in the balance. Perspect. Dev. Neurobiol. In press
27. DiFiglia M, Sapp E, Chase K, Schwarz C, Meloni A, et al. 1995. Huntingtin is a cytoplasmic protein associated with vesicles in human and rat brain neurons. Neuron 14: 1075-81
28. Doyu M, Sobue G, Mukai E, Kachi T, Yasuda T, et al. 1992. Severity of X-linked recessive bulbospinal neuronopathy correlates with size of the tandem CAG repeat in androgen receptor gene. Ann. Neurol. 32:707-10
29. Duboule D, Haenlin M, Galliot B, Mohier E. 1987. DNA sequences homologous to the Drosophila opa repeat are present in murine mRNAs that are differentially expressed in fetuses and adult tissues. Mol. Cell. Biol. 7: 2003-6
30. Dunne PW, Walch ET, Epstein HF. 1994. Phosphorylation reactions of recombinant human myotonic dystrophy protein kinase and their inhibition. Biochemistry 33:10809-14
31. Dutch-Belgian Fragile X Consortium. 1994. Fmr1 knockout mice: a model to study fragile X mental retardation. Cell 78:23-33
32. Duyao MP, Ambrose C, Myers R, Novelletto A, Persichetti F, et al. 1993. Trinucleotide repeat instability and age of onset in Huntington's disease. Nat. Genet. 4:387-92
33. Eichler EE, Holden JJ, Popovich BW, Reiss AL, Snow K, et al. 1994. Length of uninterrupted CGG repeats determines instability in the FMR1 gene. Nat. Genet. 8:88-94
34. Feng Y, Zhiang F, Lokey LK, Chastain JL, Lakkis L, et al. 1995. Translational suppression by trinucleotide repeat expansion at FMR1. Science 268:731-34
35. Ferrante RJ, Kowall NW, Cipolloni PB, Storey E, Beal MF, et al. 1993. Excitotoxic lesions in primates as a model for Huntington's disease: histopathologic and neurochemical characterization. Exp. Neurol. 119:46-71
36. Fischbeck KH, Souders D, La Spada AR. 1991. A candidate gene for X-linked spinal muscular atrophy. Adv. Neurol. 56:209-13
37. Fu YH, Friedman DL, Richards S, Pearlman JA, Gibbs RA, et al. 1993. Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. Science 260:235-38
38. Fu YH, Kuhl DPA, Pizzuti A, Pieretti M, Sutcliffe JS, et al. 1991. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell 67:1047-58
39. Fu YH, Pizzuti A, Fenwick RG, King J, Rajnarayan S, et al. 1992. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 255:1256-58
40. Gedeon AK, Baker E, Robinson H, Partington MW, Gross B, et al. 1992. Fragile X syndrome without CCG amplification has an FMR-1 deletion. Nat. Genet. 1:341-44
41. Gerber H-P, Seipel K, Georgiev O, Hofferer M, Hug M, et al. 1994. Transcriptional activation modulated by homopolymeric glutamine and proline stretches. Science 263: 808-11
42. Goldberg YP, Kremer B, Andrew SE, Theilmann J, Graham RK, et al. 1993. Molecular analysis of new mutations for Huntington's disease: intermediate alleles and sex of origin effects. Nat. Genet. 5:174-79
43. Goldberg YP, Telenius H, Hayden MR. 1994. The molecular genetics of Huntington's disease. Curr. Opin. Neurol. 7:325-32
44. Green H. 1993. Human genetic diseases due to codon reiteration: relationship to an evolutionary mechanism. Cell 74:955-56
45. Gusella JF, Wexler NS, Conneally PM, Naylor SL, Anderson MA, et al. 1983. A polymorphic marker genetically linked to Huntington's disease. Nature 306:234-38
46. Hansen RS, Gartler SM, Scott CR, Chen SH, Laird CD. 1992. Methylation analysis of CGG sites in the CpG island of the FMR1 gene. Hum. Mol. Genet. 1:571-78
47. Harding AE. 1993. Clinical features and classification of inherited ataxias. Adv. Neurol. 61:1-14
48. Harding AE, Thomas PK, Baraitser M, Bradbury PG, Morgan-Hughes JA, et al. 1982. X-linked recessive bulbospinal neuropathy: a report of ten cases. J. Neurol. Neurosurg. Psychiatry 45:1012-19
49. Harley HG, Brook JD, Rundle SA, Crow S, Reardon W, et al. 1992. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 355: 545-46
50. Harper PS. 1989. Myotonic Dystrophy. London/Philadelphia: Saunders. 2nd ed.
51. Harper PS, Morris MJ, Quarell O, eds. 1991. Huntington's Disease. Philadelphia: Saunders
52. Hersch S, Jones R, Koroshetz W, Quaid K. 1994. The neurogenetics genie: testing for the Huntington's disease mutation. Neurology 44:1369-73
53. Hirst M, Grewal P, Flannery A, Slatter R, Maher E, et al. 1995. Two new cases of FMR1 deletion associated with mental impairment. Am. J. Hum. Genet. 56:67-74
54. Hoogeveen AT, Verhey C, Bakker CE, de Graaf E, Willemsen R, et al. 1994. A tissue dependent processing and function of the FMR-1 gene product. Am. J. Hum. Genet. 55:A18 (Abstr.)
55. Huntington's Disease Collaborative Research Group. 1993. A novel gene containing a trinucleolide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 72:971-83
56. Igarashi S, Tanno Y, Onodera O, Yamazaki M, Sato S, et al. 1992. Strong correlation between the number of CAG repeats in androgen receptor genes and the clinical onset of features of spinal and bulbar muscular atrophy. Neurology 42:2300-2
57. n repeat variation and selection against expansion in sperm. Am. J. Hum. Genet. 54:575-85
58. Kao CC, Lieberman PM, Schmidt MC, Zhou Q, Pei R, et al. 1990. Cloning of a transcriptionally active human TATA binding factor. Science 248:1646-50
59. Kawaguchi Y, Okamoto T, Taniwaki M, Aizawa M, Inoue M, et al. 1994. CAG expansions in a novel gene for Machado-Joseph disease at chromosome 14q32.1. Nat. Genet. 8:221-28
60. Kennedy WR, Alter M, Sung JH. 1968. Progressive proximal spinal and bulbar muscular atrophy of late onset: a sex-linked recessive trait. Neurology 18:671-80
61. Knight SJL, Flannery AV, Hirst MC, Campbell L, Christodoulou Z, et al. 1993. Trinucleolide repeat expansion and hypermethylation of a CpG island in FRAXE mental retardation. Cell 74:127-34
62. Koide R, Ikeuchi I, Onodera O, Tanaka H, Igarishi S, et al. 1994. Unstable expansion of CAG repeat in hereditary dentatorubral-pallidoluysian atrophy (DRPLA). Nat. Genet. 6:9-13
63. Komure O, Sano A, Nishino N, Yamaguchi N, Ueno S, et al. 1995. DNA analysis in hereditary dentatorubral-pallidoluysian atrophy: correlation between CAG repeat length and phenotypic variation and the molecular basis of anticipation. Neurology 45:143-49
64. n repeat on the transcripts of DMPK alleles. Am. J. Hum. Genet. 55:A227 (Abstr.)
65. Kremer B, Goldberg P, Andrew SE, Theilman J, Telenius H, et al. 1994. A worldwide study of the Huntington's disease mutation: the sensitivity and specificity of measuring CAG repeats. New Engl. J. Med. 330:1401-6
66. n. Science 252:1711-14
67. Kuhl D, Pizzuti A, Caskey CT. 1993. Triplet repeat mutations: an important etiology of genetic disease. Curr. Opin. Neurol. 13:55-85
68. LaSpada AR, Paulson HL, Fischbeck KH. 1994. Trinucleotide repeat expansion in neurological disease. Ann. Neurol. 36:814-22
69. La Spada AR, Roling D, Harding AE, Warner CL, Spiegel R, et al. 1992. Meiotic stability and genotype-phenotype correlation of the trinucleotide repeat in X-linked spinal and bulbar muscular atrophy. Nat. Genet. 2:301-4
70. La Spada AR, Wilson EM, Lubahn DB, Harding AE, Fischbeck KH. 1991. Androgen receptor gene mutations in X-linked spinal and bulbar muscular atrophy. Nature 352:77-79
71. Li SH, Schilling G, Young WS, Li X-J, Margolis RL, et al. 1993. Huntington's disease gene (ITI5) is expressed widely in human and rat tissues. Neuron 11:985-93
72. MacDonald ME, Barnes G, Srinidi J, Duyao MP, Ambrose CM, et al. 1993. Gametic but not somatic instability of CAG repeat length in Huntington's disease. J. Med. Genet. 30: 982-86
73. Mahadevan M, Tsilfidis C, Sabourin L, Shutler G, Amemiya C, et al. 1992. Myotonic dystrophy mutation: an unstable CTG repeat in the 3′ untranslated region of the gene. Science 255:1253-55
74. Mandel J-L. 1994. Trinucleotide diseases on the rise. Nat. Genet. 7:453-55
75. Matilla T, Volpini V, Genis D, Rosell J, Corral J, et al. 1993. Presymptomatic analysis of spinocerebellar ataxia type 1 (SCA1) via the expansion of the SCA1 CAG-repeat in a large pedigree displaying anticipation and parental male bias. Hum. Mol. Genet. 2: 2123-28
76. McConkie-Rosell A, Lachiewicz AM, Spiridigliozzi GA, Tarleton J, Schoenwald S, et al. 1993. Evidence that methylation of the FMR-1 locus is responsible for variable phenotypic expression of the fragile X syndrome. Am. J. Hum. Genet. 53:800-9
77. Mhatre AN, Trifiro MA, Kaufman M, Kazemi-Esfarjani P, Figlewicz D, et al. 1993. Reduced transcriptional regulatory competence of the androgen receptor in X-linked spinal and bulbar muscular atrophy. Nat. Genet. 5: 184-88
78. Mitchell PJ, Tjian R. 1989. Transcriptional regulation in mammalian cells by sequence-specific DNA binding proteins. Science 245: 371-78
79. Modrich P. 1994. Mismatch repair, genetic stability, and cancer. Science 266:1959-60
80. n repeat in sporadic Huntington's disease. Nat. Genet. 5: 168-73
81. Nagafuchi S, Yanagisawa H, Ohsaki E, Shirayama T, Tadokoro K, et al. 1994a. Structure and expression of the gene responsible for the triplet repeat disorder, dentatorubral and pallidoluysian atrophy (DRPLA). Nat. Genet. 8:177-82
82. Nagafuchi S, Yanagisawa H, Sato K, Shirayama T, Ohsaki E, et al. 1994b. Dentatorubral and pallidoluysian atrophy expansion of an unstable CAG trinucleotide on chromosome 12p. Nat. Genet. 6:14-18
83. Naito H, Oyanagi S. 1982. Familial myoclonus epilepsy and choreoathetosis: hereditary dentatorubral-pallidoluysian atrophy. Neurology 32:798-807
84. Nancarrow JK, Kremer E, Holman K, Eyre H, Doggett NA, et al. 1994. Implications of FRA16A structure for the mechanism of chromosomal fragile site genesis. Science 264:1938-41
85. Nasir J, Floresco SB, O'Kusky JR, Dewart VM, Richman J, et al. 1995. Targeted disruption of the Huntington's disease gene results in embryonic lethality and behavioral and morphological changes in heterozygotes. Cell 81:811-23
86. Nelson DL, Warren ST. 1993. Trinucleotide repeat instability: when and where? Nat. Genet. 4:107-8
87. Neumann MN. 1959. Combined degeneration of globus pallidus and dentate nucleus and their projections. Neurology 9:430-38
88. Novelletto A, Persichetti F, Sabbadini G, Mandich P, Bellone E, et al. 1994. Analysis of the trinucleotide repeat expansion in Italian families affected with Huntington's disease. Hum. Mol. Genet. 3:93-98
89. Novelli G, Gennarelli M, Zelano G, Pizzati A, Fattorini C, et al. 1993. Failure in detecting mRNA transcripts from the mutated allele in myotonic dystrophy muscle. Biochem. Mol. Biol. Int. 29:291-97
90. Nussbaum RL, Ledbetter DH. 1989. The fragile X syndrome. In Metabolic Basis of Inherited Diseases, ed. CR Scriver, AL Beaudet, WS Sly, D Valle, pp. 327-42. New York: McGraw-Hill
91. Oberle I, Rousseau F, Heitz D, Kietz C, Devys D, et al. 1991. Instability of a 550-base pair DNA segment and abnormal methylation in fragile X syndrome. Science 252:1087-102
92. Orr HT, Chung M, Banfi S, Kwialkowski TJ, Servadio A, et al. 1993. Expansion of an unstable trinucleotide CAG repeat in spinocerebellar ataxia type 1. Nat. Genet. 4:221-26
93. Parrish JE, Oostra BA, Verkerk AJ, Richards CS, Reynolds J, et al. 1994. Isolation of a GCC repeat showing expansion in FRAXF, a fragile site distal to FRAXA and FRAXE. Nat. Genet. 8:229-35
94. Pascal E, Tjian R. 1991. Different activation domains of Sp1 govern formation of multimers and mediate transcriptional synergism. Genes Dev. 5:1646-56
95. Perutz MF, Johnson T, Suzuki M, Finch JT. 1994. Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. Proc. Natl. Acad. Sci. USA 91:5355-58
96. Pieretti M, Zhang F, Fu YH, Warren ST, Oostra BA, et al. 1991. Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66:817-22
97. Pizzuti A, Friedman DL, Caskey CT. 1993. The myotonic dystrophy gene. Arch. Neurol. 50: 1173-79
98. Ptacek LJ, Johnson KJ, Griggs RC. 1993. Genetics and physiology of the myotonic muscle disorders. New Engl. J. Med 328:482-89
99. Ranum LP, Chung M, Banfi S, Bryer A, Schut LJ, et al. 1994. Molecular and clinical correlations in spinocerebellar ataxia type 1: evidence for familial effects on the age of onset Am. J. Hum. Genet. 55:244-52
100. Rastinejad F, Blau HM. 1993. Genetic complementation reveals a novel regulatory role for 3′ untranslated regions in growth and differentiation. Cell 72:903-17
101. Redman JB, Fenwick RG, Fu Y-H, Pizzuti A, Caskey CT. 1993. Relationship between parental trinucleotide GCT repeat length and severity of myotonic dystrophy in offspring. J. Am. Med. Assoc. 269:1960-65
102. Reiss AL, Aylward E, Freund LS, Joshi PK, Bryan RN. 1991. Neuroanatomy of fragile X syndrome: the posterior fossa. Ann. Neurol. 29:26-32
103. Reyniers E, Vits L, De Boulle, Van Roy B, Van Velzen D, et al. 1993. The full mutation in the FMR-1 gene of male fragile X patients is absent in their sperm. Nat. Genet. 4:143-46
104. Richards RI, Sutherland GR. 1994. Simple DNA is not repeated simply. Nat. Genet. 6: 114-16
105. Ritchie RJ, Knight SJL, Hirst MC, Grewal PK, Bobrow M, et al. 1994. The cloning of FRAXF: trinucleotide repeat expansion and methylation at a third fragile site in distal Xqter. Hum. Mol. Genet. 3:2115-21
106. Rosenberg RN. 1992. Machado-Joseph disease: an autosomal dominant motor system degeneration. Mov. Disord. 7:193-203
107. Rosenberg RN. 1995. Autosomal dominant cerebellar phenotypes: the genotype has settled the issue. Neurology 45:1-5
108. Ross CA, McInnis MG, Margolis RL, Li S-H. 1993. Genes with triplet repeats: candidate mediators of neuropsychiatric disorders. Trends Neurosci. 16:254-60
109. Sabouri LA, Mahadevan MS, Narang M, Lee DSE, Surh LC, et al. 1993. Effect of the myotonic dystrophy (DM) mutation on mRNA levels of the DM gene. Nat. Genet. 4:233-38
110. Sarnat HB, Silben SW. 1976. Maturational arrest of fetal muscle in neonatal myotonic dystrophy. Arch. Neurol. 33:466-74
111. Schut JW. 1954. Hereditary ataxia: clinical study through six generations. Arch. Neurol. Psychiatry 63:535-67
112. Servadio A, Koshy B, Armstrong D, Antalffy B, Orr HT, Soghbi HY. 1995. Expression analysis of the ataxin-1 protein in tissues from normal and spinocerebellar ataxia type 1 individuals. Nat. Genet. 10:94-98
113. Sharp AH, Loev SJ, Schilling G, Li S-H, Li X-J, et al. 1995. Widespread expression of Huntington's disease gene (IT15) protein product. Neuron 14:1-20
114. Sherman SL, Jacobs PA, Morton NE, Froster-Iskenius U, Howard-Peebler PN, et al. 1985. Further segregation analysis of the fragile X syndrome with special reference to transmitting males. Hum. Genet. 69:289-99
115. Siomi H, Siomi MC, Nussbaum RL, Dreyfuss G. 1993. The protein product of the fragile X gene, FMR-1, has characteristics of an RNA binding protein. Cell 74:291-98
116. Simpson L, Emeson RB. 1996. RNA editing. Annu. Rev. Neurosci. 19:In press
117. Smith JK, Gonda VE, Malamud N. 1958. Unusual form of cerebellar ataxia: combined dentatorubral-pallidoluysian atrophy. Neurology 32:798-807
118. Snell RG, MacMillan JC, Cheadle JP, Fenton I, Lazarou PL, et al. 1993. Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nat. Genet. 4:393-97
119. Sobue G, Hashizume Y, Mukai E, Hirayama M, Mitsuma T, et al. 1989. X-linked recessive bulbospinal neuronopathy: a clinicopathological study. Brain 112:209-32
120. Stott K, Blackburn JM, Butler PJG, Perutz M. 1995. Incorporation of glutamine repeats makes protein oligomerize: implications for neurodegenerative diseases. Proc. Natl. Acad Sci. USA. In press
121. Strong TV, Tagle DA, Valdes JM, Elmer LW, Boehm K, et al. 1993. Widespread expression of the human and rat Huntington's disease gene in brain and nonneural tissues. Nat. Genet. 5:259-65
122. Sutcliffe JS, Nelson DL, Zhang F, Pieretti M, Caskey CT, et al. 1992. DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum. Mol. Genet. 1:397-400
123. Sutherland GR, Richards RI. 1993. Dynamic mutations on the move. J. Med. Genet. 30: 978-81
124. Takahashi H, Okama E, Naito H, Takeda S, Nakashima S, et al. 1988. Hereditary dentatorubral-pallidoluysian atrophy: clinical and pathologic variants in a family. Neurology 38:1065-70
125. Telenius H, Kremer B, Goldberg YP, Theilman J, Andrew SE, et al. 1994. Somatic and gonadal mosaicism of the Huntington disease gene CAG repeat in brain and sperm. Nat. Genet. 6:409-14
126. Thornton CA, Griggs RC, Moxley RT III. 1994. Myotonic dystrophy with no trinucleotide repeat expansion. Ann. Neurol. 35: 269-71
127. Trottier Y, Devys D, Imbert G, Saudou F, An I, et al. 1995. Cellular localization of the Huntington's disease protein and discriminiation of the normal and mutated form. Nat. Genet. 10:104-10
128. Tsilfidis C, MacKenzie AE, Mettler G, Barcelo J, Korneluk RG. 1992. Correlation between CTG trinucleotide repeat length and frequency of severe congenital myotonic dystrophy. Nat. Genet. 1:192-95
129. van der Ven PF, Jansen G, van Kuppevelt TH, Perryman MB, Lupa M, et al. 1993. Myotonic dystrophy kinase is a component of neuromuscular junctions. Hum. Mol. Genet. 2:1889-94
130. Verheij C, Bakker CE, de Graff E, Keulemana J, Willemsen R, et al. 1993. Characterization and localization of the FMR-1 gene product associated with fragile-X syndrome. Nature 363:722-24
131. Verkerk AJ, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, et al. 1991. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65:905-14
132. Vonsattel JP, Myers RH, Stevens TJ, Ferrante RJ, Bird ED, et al. 1985. Neuropathological classification of Huntington's disease. J. Neuropath. Exp. Neurol. 44:559-77
133. Warner CL, Griffen JE, Wilson JD, Jacobs LD, Murray KR, et al. 1992. X-linked spinomuscular atrophy; a kindred with associated abnormal androgen binding. Neurology 42: 2181-84
134. Wexler NS, Rose EA, Housman DE. 1991. Molecular approaches to hereditary diseases of the nervous system: Huntington's disease as a paradigm. Annu. Rev. Neurosci. 14:503-29
135. Wharton KA, Yedvobnick B, Finnerty VG, Artavanis-Tsakpnas S. 1985. opa: a novel family of transcribed repeats shared by the Notch locus and other developmentally regulated loci in D. melanogaster. Cell 40:55-62
136. Wieringa B. 1994. Myotonic dystrophy reviewed: back to the future? Hum. Mol. Genet. 3:1-7
137. Wisniewski KE, Segan SM, Miezejeski CM, Serson EA, Rudelli RD. 1991. The fragile X syndrome: neurological, electrophysiological, and neuropathological abnormalities. Am. J. Med. Genet. 38:476-80
138. Wohrle D, Hennig I, Vogel W, Steinbach P. 1993. Mitotic stability of fragile X mutations in differentiated cells indicates early post-conceptional trinucleotide repeat expansion. Nat. Genet. 4:140-42
139. Wohrle D, Kotzot D, Hirst MC, Manca A, Korn B, et al. 1992. A microdeletion of less than 250 kb, including the proximal part of the FMR-1 gene and the fragile X site, in a male with the clinical phenotype of fragile X syndrome. Am. J. Hum. Genet. 51:299-306
140. Yazawa I, Nukina N, Hashida H, Goto J, Yamada M, Kanazawa I, et al. 1995. Abnormal gene product identified in hereditary dentatorubral-pallidoluysian atrophy (DRPLA) brain. Nat. Genet. 10:99-103
141. Yu W-HA. 1989. Administration of testosterone attenuates neuronal loss following axotomy in the brain-stem motor nuclei of female rats. J. Neurosci. 9:3908-14
142. Zhang L, Leeflang EP, Yu JY, Arnheim N. 1994. Studying human mutations by sperm typing: instability of CAG trinucleotide repeats in the human androgen receptor gene. Nat. Genet. 7:531-35
143. Zhou Z-X, Wong C-I, Sar M, Wilson EM. 1994. The androgen receptor: an overview. Recent Prog. Hormone Res. 49:249-74